Welcome to LookChem.com Sign In|Join Free
  • or
7-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

51726-79-5

Post Buying Request

51726-79-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51726-79-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 51726-79-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,7,2 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 51726-79:
(7*5)+(6*1)+(5*7)+(4*2)+(3*6)+(2*7)+(1*9)=125
125 % 10 = 5
So 51726-79-5 is a valid CAS Registry Number.

51726-79-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Hydroxy-7-nitro-3-quinolinecarboxylic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51726-79-5 SDS

51726-79-5Upstream product

51726-79-5Relevant academic research and scientific papers

Synthesis of 1,4-Dihydro-4-oxo-quinoline-3-carboxylic Acid Derivatives as Inhibitors of Rat Lens Aldose Reductase

Bueyuekbingoel, Erdem,Das, Net,Klopman, Gilles

, p. 129 - 132 (1994)

The title compounds were prepared according to Scheme 2 and tested as inhibitors of the aldose reductase of rat lens.

Polysubstituted quinolone compounds, and preparation method and use thereof

-

Paragraph 0131; 0132; 0133; 0331; 0332; 0333, (2017/09/19)

The invention provides polysubstituted quinolone compounds, and a preparation method and a use thereof, and concretely provides a polysubstituted quinolone compound represented by formula I, and optical isomers, pharmaceutically acceptable salts or solvates thereof. All groups in the formula I are defined in the description. The quinolone compound has excellent c-Met inhibition activity, and can be used for treating c-Met activity or expression level corrected diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51726-79-5